Education
About Us
Working with TipRanks
Follow Us
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 56.62M | $ 63.07M | $ 61.47M | $ 60.01M | $ 56.11M |
| Gross Profit | $ 47.62M | $ 55.45M | $ 56.49M | $ 56.04M | $ 52.48M |
| Operating Income | $ -7.69M | $ -10.35M | $ -13.44M | $ -6.24M | $ -11.26M |
| EBITDA | $ 17.22M | $ 12.88M | $ 18.00M | $ 25.41M | $ 23.19M |
| Net Income | $ -19.66M | $ -27.53M | $ -23.60M | $ -13.12M | $ -15.33M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 17.46M | $ 21.95M | $ 20.72M | $ 21.18M | $ 20.61M |
| Total Assets | $ 159.90M | $ 209.06M | $ 241.65M | $ 275.90M | $ 303.91M |
| Total Debt | $ 66.45M | $ 87.62M | $ 97.34M | $ 97.57M | $ 107.12M |
| Net Debt | $ 48.99M | $ 65.67M | $ 76.62M | $ 76.39M | $ 86.51M |
| Total Liabilities | $ 88.56M | $ 111.36M | $ 116.33M | $ 115.17M | $ 134.66M |
| Stockholders' Equity | $ 71.34M | $ 97.70M | $ 125.32M | $ 160.74M | $ 169.25M |
| Cash Flow | |||||
| Free Cash Flow | $ 7.99M | $ 15.60M | $ 6.79M | $ 11.92M | $ -35.33M |
| Operating Cash Flow | $ 8.00M | $ 15.79M | $ 16.94M | $ 16.43M | $ 9.34M |
| Investing Cash Flow | $ 11.73M | $ -189.00K | $ -10.15M | $ -4.51M | $ -44.68M |
| Financing Cash Flow | $ -23.36M | $ -14.64M | $ -6.86M | $ -11.40M | $ 9.56M |